Supriya Lifescience has received Good Manufacturing Practice (GMP) certification from the Regulatory Authority of Brazil, ANVISA for its manufacturing site in Lote Parshuram. This success in the rigorous GMP inspection underscores Supriya’s commitment to the highest quality standards and the excellence of its smart manufacturing practices.
The clearance of this audit marks the successful registration of 8 APIs with CADIFA and will further enable smoother and faster registration of the company’s other APIs. This Successful Inspection paves the way for Supriya Lifescience to acquire more customers in the Brazilian Pharmaceutical market.
Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |